The following have contributed to this page: Peter Bramlage
Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?
- Anselm K. Gitt, Martin Halle, Markolf Hanefeld, Monika Kellerer, Nikolaus Marx, Juris J. Meier, Petra-Maria Schumm-Draeger, Peter Bramlage, Diethelm Tschöpe
- European Journal of Heart Failure, December 2012, Wiley
- DOI: 10.1093/eurjhf/hfs136